Literature DB >> 11306597

Beta-adrenergic receptors in the failing heart: the good, the bad, and the unknown.

S B Liggett1.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11306597      PMCID： PMC199564          DOI： 10.1172/JCI12774

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  27 in total

1.  Transgenic Galphaq overexpression induces cardiac contractile failure in mice.

Authors:  D D D'Angelo; Y Sakata; J N Lorenz; G P Boivin; R A Walsh; S B Liggett; G W Dorn
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

2.  Mechanisms of impaired beta-adrenergic receptor signaling in G(alphaq)-mediated cardiac hypertrophy and ventricular dysfunction.

Authors:  G W Dorn; N M Tepe; G Wu; A Yatani; S B Liggett
Journal:  Mol Pharmacol       Date:  2000-02       Impact factor: 4.436

3.  The beta2-adrenergic receptor interacts with the Na+/H+-exchanger regulatory factor to control Na+/H+ exchange.

Authors:  R A Hall; R T Premont; C W Chow; J T Blitzer; J A Pitcher; A Claing; R H Stoffel; L S Barak; S Shenolikar; E J Weinman; S Grinstein; R J Lefkowitz
Journal:  Nature       Date:  1998-04-09       Impact factor: 49.962

4.  Mice expressing mutant myosin heavy chains are a model for familial hypertrophic cardiomyopathy.

Authors:  K L Vikstrom; S M Factor; L A Leinwand
Journal:  Mol Med       Date:  1996-09       Impact factor: 6.354

5.  Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A.

Authors:  Y Daaka; L M Luttrell; R J Lefkowitz
Journal:  Nature       Date:  1997-11-06       Impact factor: 49.962

6.  Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy.

Authors:  S Minamisawa; M Hoshijima; G Chu; C A Ward; K Frank; Y Gu; M E Martone; Y Wang; J Ross; E G Kranias; W R Giles; K R Chien
Journal:  Cell       Date:  1999-10-29       Impact factor: 41.582

7.  Transgenic replacement of type V adenylyl cyclase identifies a critical mechanism of beta-adrenergic receptor dysfunction in the G alpha q overexpressing mouse.

Authors:  N M Tepe; S B Liggett
Journal:  FEBS Lett       Date:  1999-09-17       Impact factor: 4.124

8.  Altering the receptor-effector ratio by transgenic overexpression of type V adenylyl cyclase: enhanced basal catalytic activity and function without increased cardiomyocyte beta-adrenergic signalling.

Authors:  N M Tepe; J N Lorenz; A Yatani; R Dash; E G Kranias; G W Dorn; S B Liggett
Journal:  Biochemistry       Date:  1999-12-14       Impact factor: 3.162

9.  Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor.

Authors:  W J Koch; H A Rockman; P Samama; R A Hamilton; R A Bond; C A Milano; R J Lefkowitz
Journal:  Science       Date:  1995-06-02       Impact factor: 47.728

10.  Functional receptor coupling to Gi is a mechanism of agonist-promoted desensitization of the beta2-adrenergic receptor.

Authors:  N M Tepe; S B Liggett
Journal:  J Recept Signal Transduct Res       Date:  2000-01       Impact factor: 2.092
View more
  13 in total

1.  Tight control of adrenal medulla catecholamine release by alpha 2C-adrenergic receptors influences susceptibility to heart failure.

Authors:  Natalia Petrashevskaya; Stephen B Liggett
Journal:  Cardiovasc Res       Date:  2007-07-16       Impact factor: 10.787

2.  Agonizing over agonism: should asthmatics turn their beta-receptors on or off?

Authors:  Raymond B Penn
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-11       Impact factor: 11.205

3.  Association of in vivo β-adrenergic receptor sensitivity with inflammatory markers in healthy subjects.

Authors:  Frank Euteneuer; Paul J Mills; Winfried Rief; Michael G Ziegler; Joel E Dimsdale
Journal:  Psychosom Med       Date:  2012-02-24       Impact factor: 4.312

4.  Complex haplotypes derived from noncoding polymorphisms of the intronless alpha2A-adrenergic gene diversify receptor expression.

Authors:  Kersten M Small; Kari M Brown; Carrie A Seman; Cheryl T Theiss; Stephen B Liggett
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

Review 5.  β-Adrenergic receptor, an essential target in cardiovascular diseases.

Authors:  Daniel Chikere Ali; Muhammad Naveed; Andrew Gordon; Fatima Majeed; Muhammad Saeed; Michael I Ogbuke; Muhammad Atif; Hafiz Muhammad Zubair; Li Changxing
Journal:  Heart Fail Rev       Date:  2020-03       Impact factor: 4.214

6.  A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure.

Authors:  Stephen B Liggett; Sharon Cresci; Reagan J Kelly; Faisal M Syed; Scot J Matkovich; Harvey S Hahn; Abhinav Diwan; Jeffrey S Martini; Li Sparks; Rohan R Parekh; John A Spertus; Walter J Koch; Sharon L R Kardia; Gerald W Dorn
Journal:  Nat Med       Date:  2008-04-20       Impact factor: 53.440

7.  Antithetic regulation by beta-adrenergic receptors of Gq receptor signaling via phospholipase C underlies the airway beta-agonist paradox.

Authors:  Dennis W McGraw; Khalid F Almoosa; Richard J Paul; Brian K Kobilka; Stephen B Liggett
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

8.  Inverse agonism and its therapeutic significance.

Authors:  Gurudas Khilnani; Ajeet Kumar Khilnani
Journal:  Indian J Pharmacol       Date:  2011-09       Impact factor: 1.200

9.  Cardiac disease in adolescents with delayed diagnosis of vertically acquired HIV infection.

Authors:  Robert F Miller; Juan P Kaski; James Hakim; Jonathan Matenga; Kusum Nathoo; Shungu Munyati; Sujal R Desai; Elizabeth L Corbett; Rashida A Ferrand
Journal:  Clin Infect Dis       Date:  2012-10-24       Impact factor: 9.079

Review 10.  The influence of diabetes on cardiac beta-adrenoceptor subtypes.

Authors:  V Melih Altan; Ebru Arioglu; Sahika Guner; A Tanju Ozcelikay
Journal:  Heart Fail Rev       Date:  2007-03-16       Impact factor: 4.654
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.